1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. ANTIBIOTIC MARKET BY DRUG CLASS
5.1. Introduction
5.2. Penicillins
5.3. Cephalosporins
5.4. Fluoroquinolones
5.5. Macrolides
5.6. Tetracyclines
5.7. Aminoglycosides
5.8. Others
6. ANTIBIOTIC MARKET BY SPECTRUM OF ACTIVITY
6.1. Introduction
6.2. Broad-Spectrum Antibiotics
6.3. Narrow-Spectrum Antibiotics
7. ANTIBIOTIC MARKET BY ROUTE OF ADMINISTRATION
7.1. Introduction
7.2. Oral
7.3. Intravenous
7.4. Intramuscular
7.5. Others
8. ANTIBIOTIC MARKET BY APPLICATION
8.1. Introduction
8.2. Hospital-Acquired Infections (HAIs)
8.3. Community-Acquired Infections (CAIs)
8.4. Urinary Tract Infections (UTIs)
8.5. Respiratory Tract Infections
8.6. Skin and Soft Tissue Infections
8.7. Others
9. ANTIBIOTIC MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. United Kingdom
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. Japan
9.6.3. India
9.6.4. South Korea
9.6.5. Taiwan
9.6.6. Thailand
9.6.7. Indosneisa
9.6.8. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Pfizer Inc.
11.2. GlaxoSmithKline plc (GSK)
11.3. Merck & Co., Inc.
11.4. Novartis AG
11.5. Roche Holding AG
11.6. Sanofi S.A.
11.7. AstraZeneca plc
11.8. Johnson & Johnson
11.9. Bayer AG
11.10. AbbVie Inc.
11.11. MELINTA THERAPEUTICS, INC.
11.12. Cipla Inc.
11.13. Sun Pharmaceutical Industries Ltd.
11.14. Dr. Reddy’s Laboratories Ltd.
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES